UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Hypoglycemia, Chronic Kidney Disease, and Diabetes Mellitus

Mayo Clinic proceedings, 2014-11, Vol.89 (11), p.1564-1571

2014

Volltextzugriff (PDF)

Is Reduced First-Phase Insulin Release the Earliest Detectable Abnormality in Individuals Destined to Develop Type 2 Diabetes?

Diabetes (New York, N.Y.), 2002-02, Vol.51 (suppl 1), p.S117-S121

GERICH, John E

2002

Volltextzugriff (PDF)

Contributions of Insulin-Resistance and Insulin-Secretory Defects to the Pathogenesis of Type 2 Diabetes Mellitus

Mayo Clinic proceedings, 2003-04, Vol.78 (4), p.447-456

Gerich, John E.

2003

Volltextzugriff (PDF)

Type 2 diabetes: postprandial hyperglycemia and increased cardiovascular risk

Vascular health and risk management, 2010-01, Vol.6 (default), p.145-155

2010

Volltextzugriff (PDF)

The Genetic Basis of Type 2 Diabetes Mellitus: Impaired Insulin Secretion versus Impaired Insulin Sensitivity

Endocrine reviews, 1998-08, Vol.19 (4), p.491-503

Gerich, John E

1998

Volltextzugriff (PDF)

The Role of α-Cell Dysregulation in Fasting and Postprandial Hyperglycemia in Type 2 Diabetes and Therapeutic Implications

Endocrine reviews, 2007-05, Vol.28 (3), p.253-283

2007

Volltextzugriff (PDF)

Metabolic Effects of Metformin in Non-Insulin-Dependent Diabetes Mellitus

The New England journal of medicine, 1995-08, Vol.333 (9), p.550-554

1995

Volltextzugriff (PDF)

Hypoglycemia in Patients with Diabetes and Renal Disease

Journal of clinical medicine, 2015-05, Vol.4 (5), p.948-964

2015

Volltextzugriff (PDF)

Efficacy and Safety of the Once-Daily GLP-1 Receptor Agonist Lixisenatide in Monotherapy: A randomized, double-blind, placebo-controlled trial in patients with type 2 diabetes (GetGoal-Mono)

Diabetes care, 2012-06, Vol.35 (6), p.1225-1231

2012

Volltextzugriff (PDF)

Role of human liver, kidney, and skeletal muscle in postprandial glucose homeostasis

American journal of physiology: endocrinology and metabolism, 2002-02, Vol.282 (2), p.E419-E427

2002

Volltextzugriff (PDF)

Abnormal renal, hepatic, and muscle glucose metabolism following glucose ingestion in type 2 diabetes

American journal of physiology: endocrinology and metabolism, 2004-12, Vol.287 (6), p.E1049-E1056

2004

Volltextzugriff (PDF)

Impaired Hyperglycemia-Induced Delay in Gastric Emptying in Patients With Type 1 Diabetes Deficient for Islet Amyloid Polypeptide

Diabetes care, 2008-12, Vol.31 (12), p.2325-2331

2008

Volltextzugriff (PDF)

Mechanisms for abnormal postprandial glucose metabolism in type 2 diabetes

American journal of physiology: endocrinology and metabolism, 2006-01, Vol.290 (1), p.E67-E77

2006

Volltextzugriff (PDF)

Mechanisms for the Deterioration in Glucose Tolerance Associated With HIV Protease Inhibitor Regimens

Diabetes (New York, N.Y.), 2003-04, Vol.52 (4), p.918-925

2003

Volltextzugriff (PDF)

Role of the Decrement in Intraislet Insulin for the Glucagon Response to Hypoglycemia in Humans

Diabetes care, 2005-05, Vol.28 (5), p.1124-1131

2005

Volltextzugriff (PDF)

Effect of Aging on Glucose Homeostasis: Accelerated deterioration of β-cell function in individuals with impaired glucose tolerance

Diabetes care, 2008-03, Vol.31 (3), p.539-543

2008

Volltextzugriff (PDF)

Clinical significance, pathogenesis, and management of postprandial hyperglycemia

Archives of internal medicine (1960), 2003-06, Vol.163 (11), p.1306

Gerich, John E

2003

Volltextzugriff (PDF)

Renal gluconeogenesis: Its importance in human glucose homeostasis

Diabetes care, 2001-02, Vol.24 (2), p.382-391

2001

Volltextzugriff (PDF)

Increasing the Decrement in Insulin Secretion Improves Glucagon Responses to Hypoglycemia in Advanced Type 2 Diabetes

Diabetes care, 2005-11, Vol.28 (11), p.2691-2696

2005

Volltextzugriff (PDF)

Disturbances in β-Cell Function in Impaired Fasting Glycemia

Diabetes (New York, N.Y.), 2002-02, Vol.51 (suppl 1), p.S265-S270

2002

Volltextzugriff (PDF)

Use of Inhaled Insulin in a Basal/Bolus Insulin Regimen in Type 1 Diabetic Subjects: A 6-month, randomized, comparative trial

Diabetes care, 2005-07, Vol.28 (7), p.1630-1635

2005

Volltextzugriff (PDF)

Development of the sodium-glucose co-transporter 2 inhibitor dapagliflozin for the treatment of patients with Type 2 diabetes mellitus

Expert review of clinical pharmacology, 2011-11, Vol.4 (6), p.669-683

2011

Volltextzugriff (PDF)

Efficacy and Safety of Lixisenatide Once Daily Versus Exenatide Twice Daily in Type 2 Diabetes Inadequately Controlled on Metformin: A 24-week, randomized, open-label, active-controlled study (GetGoal-X)

Diabetes care, 2013-10, Vol.36 (10), p.2945-2951

2013

Volltextzugriff (PDF)

Postprandial hyperglycemia and cardiovascular disease

Endocrine practice, 2006-01, Vol.12 Suppl 1, p.47-51

Gerich, John E

2006

Volltextzugriff (PDF)

Insulin glargine: long-acting basal insulin analog for improved metabolic control

Current medical research and opinion, 2004, Vol.20 (1), p.31-37

Gerich, John E.

2004

Volltextzugriff (PDF)

1 – 25 von 201

Suche als RSS-Feed

Aktive Filter

KollektionScienceDirect

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(171)
Mit Volltextzugriff
(112)

Publikationsform

Sprache

Englisch
(201)

Erscheinungsjahr

n.n

Thema

Humans
(133)
Science & Technology
(104)
Life Sciences & Biomedicine
(102)
Male
(81)
Adult
(68)
Female
(67)
Biological And Medical Sciences
(62)
Endocrinology & Metabolism
(57)
Blood Glucose - Metabolism
(53)
Insulin - Blood
(53)
Medical Sciences
(53)
Endocrinopathies
(39)
Middle Aged
(39)
Endocrine Pancreas. Apud Cells
(38)
Diabetes. Impaired Glucose Tolerance
(37)
Diabetes
(36)
Glucagon - Blood
(35)
General & Internal Medicine
(32)
Glucose
(32)
Medicine, General & Internal
(32)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Hypoglycemia, Chronic Kidney Disease, and Diabetes Mellitus

Is Reduced First-Phase Insulin Release the Earliest Detectable Abnormality in Individuals Destined to Develop Type 2 Diabetes?

Contributions of Insulin-Resistance and Insulin-Secretory Defects to the Pathogenesis of Type 2 Diabetes Mellitus

Type 2 diabetes: postprandial hyperglycemia and increased cardiovascular risk

The Genetic Basis of Type 2 Diabetes Mellitus: Impaired Insulin Secretion versus Impaired Insulin Sensitivity

The Role of α-Cell Dysregulation in Fasting and Postprandial Hyperglycemia in Type 2 Diabetes and Therapeutic Implications

Metabolic Effects of Metformin in Non-Insulin-Dependent Diabetes Mellitus

Hypoglycemia in Patients with Diabetes and Renal Disease

Efficacy and Safety of the Once-Daily GLP-1 Receptor Agonist Lixisenatide in Monotherapy: A randomized, double-blind, placebo-controlled trial in patients with type 2 diabetes (GetGoal-Mono)

Role of human liver, kidney, and skeletal muscle in postprandial glucose homeostasis

Abnormal renal, hepatic, and muscle glucose metabolism following glucose ingestion in type 2 diabetes

Impaired Hyperglycemia-Induced Delay in Gastric Emptying in Patients With Type 1 Diabetes Deficient for Islet Amyloid Polypeptide

Mechanisms for abnormal postprandial glucose metabolism in type 2 diabetes

Mechanisms for the Deterioration in Glucose Tolerance Associated With HIV Protease Inhibitor Regimens

Role of the Decrement in Intraislet Insulin for the Glucagon Response to Hypoglycemia in Humans

Effect of Aging on Glucose Homeostasis: Accelerated deterioration of β-cell function in individuals with impaired glucose tolerance

Clinical significance, pathogenesis, and management of postprandial hyperglycemia

Renal gluconeogenesis: Its importance in human glucose homeostasis

Increasing the Decrement in Insulin Secretion Improves Glucagon Responses to Hypoglycemia in Advanced Type 2 Diabetes

Disturbances in β-Cell Function in Impaired Fasting Glycemia

Use of Inhaled Insulin in a Basal/Bolus Insulin Regimen in Type 1 Diabetic Subjects: A 6-month, randomized, comparative trial

Development of the sodium-glucose co-transporter 2 inhibitor dapagliflozin for the treatment of patients with Type 2 diabetes mellitus

Efficacy and Safety of Lixisenatide Once Daily Versus Exenatide Twice Daily in Type 2 Diabetes Inadequately Controlled on Metformin: A 24-week, randomized, open-label, active-controlled study (GetGoal-X)

Postprandial hyperglycemia and cardiovascular disease

Insulin glargine: long-acting basal insulin analog for improved metabolic control

Aktive Filter

Suchergebnisse filtern